I've referenced an evidence-tier framework repeatedly across this site without ever giving it a dedicated home. This post is that home. Going forward, every peptide-specific post in this series will point back here rather than re-explaining the reasoning each time — so I want to lay it out properly, once, and be precise about it.
Two separate questions, often collapsed into one
When someone asks "is this peptide legitimate," they're usually actually asking two different questions at once, and I think keeping them separate is the single most useful thing a patient can do when evaluating any peptide they've heard about.
Question one: what is its regulatory status? I covered this in the last post — FDA-approved prescription drug, compounded under a legitimate pharmacy pathway, or research chemical with no human-use sanction. This is a legal and manufacturing-quality question.
Question two: how strong is the evidence that it actually does what it's claimed to do? This is a separate, scientific question, and a peptide's answer to question one doesn't automatically determine its answer to question two — though the two are correlated for good reason, since the approval process itself is what generates the strongest evidence.
Collapsing these into a single "legitimate or not" judgment is where I think a lot of public conversation about peptides goes wrong. A peptide can have a genuinely interesting, biologically plausible mechanism and still have thin human evidence. A peptide can be moving toward a real regulatory pathway and still not be an approved therapeutic. Precision about which question you're actually answering matters.
The evidence tiers I use
This is the framework I've applied throughout this site, made explicit:
Tier 1: Randomized controlled human trials, ideally multiple, at meaningful scale. This is the strongest evidence available in medicine. Semaglutide, tirzepatide, and tesamorelin all sit here — I've walked through this level of evidence in detail in the post on reading STEP and SURMOUNT trial data. When I make a claim at this tier, I'm making it with real confidence.
Tier 2: Human data that's real but more limited — smaller trials, secondary or post-hoc analyses, or observational human data rather than large randomized trials. This tier supports a claim like "promising, worth watching" but not "established." Some of the leptin and adiponectin research I covered in an earlier post sits partly in this tier.
Tier 3: Mechanistic and preclinical evidence — animal studies, cell-culture research, and biological plausibility grounded in real, published science, but without human trials demonstrating the specific therapeutic claim. MOTS-c's relationship to adiponectin, which I described in an earlier post, is a good example: genuinely elegant, published biology, entirely in mice and cultured cells so far.
Tier 4: Theoretical plausibility without direct supporting data — a mechanism that makes biological sense based on known pathways, but hasn't itself been directly tested even in animal models for the specific claim being made.
Why I insist on naming the tier explicitly
I think the biggest disservice done in peptide-related content — on this site's part if I'm not careful, and very commonly elsewhere — is describing tier 3 or tier 4 evidence using language that implies tier 1 confidence. "Studies show" technically covers all four tiers, which is exactly why it's not a phrase I want to rely on without qualification. Every peptide-specific post in this series will state, directly, which tier the central claims sit at, using this same four-tier structure, so the language stays consistent across the whole pillar rather than drifting post to post.
This isn't about being pessimistic regarding lower-tier evidence. Tier 3 and tier 4 findings are often exactly where genuinely important discoveries start — today's Tier 1 therapies were frequently yesterday's promising mouse data. The goal isn't to dismiss early research. It's to describe it accurately, so a reader can calibrate their own expectations correctly rather than assuming "backed by research" means "backed by the same kind of research behind semaglutide."
A framework that isn't unique to this site
I want to note that this general approach — evaluating mechanism, evidence strength, safety data, and regulatory status as separate axes rather than one collapsed judgment — isn't something I invented. It's broadly how careful evaluation of any emerging therapeutic should work, and it's the same structure independently used by other physicians working in this space, including in recent public discussion of peptides by longevity-focused researchers. Different practitioners will land in different places on specific compounds, but converging on the same underlying method for asking the question is, I think, a good sign for the field generally.
How this connects to the comprehensive-care philosophy on this site
This ties directly back to something I established in an earlier post on GLP-1 therapy and longevity research: medicine often has to act on mechanistic plausibility and careful risk-benefit judgment before RCT-level proof exists, particularly within a comprehensive, multi-component care plan. That principle doesn't mean every tier gets treated the same. It means a tier 3 or tier 4 component, when it's genuinely part of a patient's care, gets used deliberately, disclosed honestly, and monitored closely — never presented as though it carries tier 1 confidence it hasn't earned.
What I'd want you to take from this
Whenever a specific peptide comes up in future posts on this site, I'll name its regulatory status and its evidence tier explicitly, using the framework laid out here. If you're evaluating a peptide you've encountered elsewhere — in a wellness forum, a supplement listing, or a conversation with a provider — I'd encourage asking both questions separately: what's its actual regulatory status, and what tier of evidence supports the specific claim being made about it. Those two questions, asked clearly, will tell you more than any single word like "legitimate" or "backed by science" ever could.
Curious where a specific peptide you've heard about falls on this framework?
No spam. Occasional new posts and updates from The Center for Metabolic Health.
Medical disclaimer: This content is provided for general educational and informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any condition, and it does not create a physician-patient relationship. Every patient's medical history, health status, and treatment needs are different. Always consult your own physician or qualified healthcare provider before starting, stopping, or changing any medication or treatment, and before making any decisions based on information found here. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room.